Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Alex Mutebi"'
Autor:
Allison Rosenthal, Javier Munoz, Monika Jun, Tongsheng Wang, Alex Mutebi, Anthony Wang, Shibing Yang, Kojo Osei-Bonsu, Brian Elliott, Fernando Rivas Navarro, Junhua Yu, Samantha Brodkin, Mariana Sacchi, Andrew Ip
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-5 (2024)
Abstract Many therapies are available for the treatment of relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) after ≥ 2 lines of therapy, albeit with scant evidence on the comparative effectiveness of these therapies. This study used i
Externí odkaz:
https://doaj.org/article/e75a738adf2847b3ace1b34ecd6f5b70
Autor:
Allison Rosenthal, Monika Jun, Javier Munoz, Tongsheng Wang, Alex Mutebi, Anthony Wang, Shibing Yang, Kojo Osei-Bonsu, Brian Elliott, Anupama Kalsekar, Fernando Rivas Navarro, Andrew Ip
Publikováno v:
HemaSphere, Vol 7, p e9299527 (2023)
Externí odkaz:
https://doaj.org/article/9afbff3cd0f44ccea61fe3b3f649d793
Autor:
Catherine Thieblemont, Christopher Fox, Anthony Wang, Kavita Sail, Abualbishr Alshreef, Michael Moran, Alex Mutebi, Julie Blaedel, Viktor Chirikov, Gilles Salles
Publikováno v:
HemaSphere, Vol 7, p e006348e (2023)
Externí odkaz:
https://doaj.org/article/58e75a3fa456429f8b0396cffeac5e0e
Autor:
Jennifer Crombie, Monika Jun, Tongsheng Wang, Alex Mutebi, Anthony Wang, Anindit Chibber, Rajesh Kamalakar, Jon Ukropec, Julie Blaedel, Anupama Kalsekar
Publikováno v:
HemaSphere, Vol 7, p e0888870 (2023)
Externí odkaz:
https://doaj.org/article/c5d2b568cbff4ddabfe6e65805803648
Autor:
Andrew Ip, Allison Rosenthal, Alex Mutebi, Tongsheng Wang, Monika Jun, Anthony Wang, Junhua Yu, Samantha Brodkin, Mariana Sacchi, Anupama Kalsekar, Javier Munoz
Publikováno v:
HemaSphere, Vol 7, p e324937a (2023)
Externí odkaz:
https://doaj.org/article/f37f24ae8af844fbb289310b5d4edb9b
Autor:
Sally D Miller, Greta Lozano-Ortega, Alex Mutebi, Owanate Briggs, Kavita Sail, Brian Elliott, Anupama Kalsekar
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 12, Iss 1 (2022)
Aim: To evaluate trials of systemic therapies in transplant-ineligible or -experienced, relapsed/refractory diffuse large-B cell lymphoma and the impact of patient characteristics on overall response rate (ORR). Patients & methods: Systematically r
Externí odkaz:
https://doaj.org/article/be8020763af24c6a81f85df7e89ac718
Autor:
Tycel Phillips, Junhua Yu, Rajesh Kamalakar, Kalatu R. Davies, Alex Mutebi, Savreet Bains Chawla, Donald Arnette, Syed Quadri, Anthony Wang
Publikováno v:
Blood. 140:5241-5243
Autor:
Sally D, Miller, Greta, Lozano-Ortega, Alex, Mutebi, Owanate, Briggs, Kavita, Sail, Brian, Elliott, Anupama, Kalsekar
Publikováno v:
Journal of Comparative Effectiveness Research. 12
Aim: To evaluate trials of systemic therapies in transplant-ineligible or -experienced, relapsed/refractory diffuse large-B cell lymphoma and the impact of patient characteristics on overall response rate (ORR). Patients & methods: Systematically rev
Autor:
Dai Chihara, Karissa Johnston, Talshyn Bolatova, Shelagh Szabo, Anupama Kalsekar, Alex Mutebi, Huiying Yang, Yangyang Liu, Dionna Attinson, Martin Hutchings
Publikováno v:
Clinical lymphoma, myelomaleukemia. 22(12)
Prevalence is reflective of disease incidence and survival, and defined as the number of patients living with active disease. In diseases such as diffuse large B-cell lymphoma (DLBCL) with treatments with curative potential, a proportion of patients
Autor:
Tycel Phillips, Pieternella Lugtenburg, Anupama Kalsekar, Alex Mutebi, Anthony Wang, Julie Blaedel, Katherine Kosa, Susan Martin, Mariana Sacchi, Catherine Thieblemont
Publikováno v:
Blood. 140:8022-8023